Maximum International

Avocado300 Soy Unsaponifiables

F
N+ Score41
Joint & BoneServing: 2 Tablet(s)Type: Other Combinations

Avocado300 Soy Unsaponifiables by Maximum International is an "Other Combinations" supplement within the Joint & Bone category. It provides 168 mg of Calcium, 300 mg of Avocado Soy Unsaponifiables, and 600 mg of SierraSil®. This product holds an N+ Score of 41, earning it an "F" grade, indicating a below-average quality assessment. The Calcium dosage is identified as underdosed relative to commonly recommended daily intakes. While Avocado Soy Unsaponifiables are often researched for joint health, the specific blend and dosages here, alongside the underdosed Calcium, contribute to the lower N+ Score. This product might be considered by those exploring joint support supplements with botanical and mineral components, but clinical efficacy at these specific dosages is not fully established.

About This Product

Avocado300 Soy Unsaponifiables by Maximum International is a joint & bone supplement containing 3 active ingredients. It has earned an N+ Score of 41/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy0/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity72/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • −Several ingredients below clinically effective doses
  • −Missing several expected ingredients for its category

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
Calcium168.000 mgUnder
Avocado Soy Unsaponifiables300.000 mgN/A
SierraSil(R)600.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.